此次集采于2022年9月正式启动，由湖北牵头，北京、天津等30个省级行政单位参与。集采涉及16个品种，共296款剂型、规格不一的药品，被业内认为是中成药的“国采”。中选企业包括益佰制药、吉林敖东、众生药业、科伦药业等多家上市药企。

zhongxinzhengquanhongguanjingjishouxifenxishichengqiangdengrenwei，gongyezhichengpinjiagedimihuorengjiangzhiyuehexinCPIdexiufufudu，dangaixiangyufuwujiagedefenhuachengdujiangyousuoshoulian，zhuroujiagerengzaixiadiequjianjiangduishipinxiangCPIgouchengyidingtuolei。zongheeryan，yuji6yueCPItongbijiangzai0.1%fujindediweipaihuai，quannianditongzhanghuanjingbubian。中(zhong)信(xin)证(zheng)券(quan)宏(hong)观(guan)经(jing)济(ji)首(shou)席(xi)分(fen)析(xi)师(shi)程(cheng)强(qiang)等(deng)认(ren)为(wei)，(，)工(gong)业(ye)制(zhi)成(cheng)品(pin)价(jia)格(ge)低(di)迷(mi)或(huo)仍(reng)将(jiang)制(zhi)约(yue)核(he)心(xin)C(C)P(P)I(I)的(de)修(xiu)复(fu)幅(fu)度(du)，(，)但(dan)该(gai)项(xiang)与(yu)服(fu)务(wu)价(jia)格(ge)的(de)分(fen)化(hua)程(cheng)度(du)将(jiang)有(you)所(suo)收(shou)敛(lian)，(，)猪(zhu)肉(rou)价(jia)格(ge)仍(reng)在(zai)下(xia)跌(die)区(qu)间(jian)将(jiang)对(dui)食(shi)品(pin)项(xiang)C(C)P(P)I(I)构(gou)成(cheng)一(yi)定(ding)拖(tuo)累(lei)。(。)综(zong)合(he)而(er)言(yan)，(，)预(yu)计(ji)6(6)月(yue)C(C)P(P)I(I)同(tong)比(bi)将(jiang)在(zai)0.(.)1(1)%(%)附(fu)近(jin)的(de)低(di)位(wei)徘(pai)徊(huai)，(，)全(quan)年(nian)低(di)通(tong)胀(zhang)环(huan)境(jing)不(bu)变(bian)。(。)